Explore all subjects

The Expertise Imperative and Compliance Technology
Access to a diverse array of specialized expert inputs drives superior decisions in every organizational context: within corporations, by investors and consultancies, and within nonprofits. When decision makers are confident of their decision inputs, they can respond more quickly and creatively to challenges and opportunities.Learn more about GLG's Compliance Framework


This page may include content provided by Council Members, your access to which is subject to the Terms of Use.
Find Out More

GLG News by Cosmetic Dermatologists

November 8, 2007
me too drug!
Analysis of: A.T.S. Pharmaceuticals, A Division Of Auriga Laboratories, Launches Coraz™ Lotion For The Treatment Of Seborrheic Dermatitis (www.medicalnewstoday.com)
Why bother with this branded 2% hydrocortisone lotion?  Likely third tier, and nothing special other than the gimicky wash that goes along with it.  The lotion is a very weak %of steroid- so probably minimally useful. ? pediatric indication, would possibly have some hope for the product.
Analysis of: Nonpayment for Performance? Medicare's New Reimbursement Rule (content.nejm.org)
This is an absurdity. 
Sunil Dhawan, MD, Clinical Assistant Professor of Dermatology
Sunil Dhawan, MD, Clinical Assistant Professor of Dermatology
Stanford University
Analysis of: Abbott's ABT-874 Shows Positive Results for Maintenance of Response in Phase II Psoriasis Study (www.pipelinereview.com)
Abbotts ABT-874 monoclonal antibody for psoriasis shows impressive results in the phase 2 trial. The results were up to 90% of patients achieving at least 75% reduction in their psoriasis. These results are as good or better than those with Remicade the most effective biologic for psoriasis currently....
Sunil Dhawan, MD, Clinical Assistant Professor of Dermatology
Sunil Dhawan, MD, Clinical Assistant Professor of Dermatology
Stanford University
Analysis of: Relieva Exceeds Expectations In Recent Clinical Trial For Eczema (Atopic Dermatitis) (www.medicalnewstoday.com)
The recent results for a trial of Relieva in atopic dermatitis or eczema, a cream containing a homeopathic compound, were positive by a report from the company. The study sample was small, and the trial was open label. Generally these trials have a larger number of patients, and are blinded. Also it...
Analysis of: Feel Pudgy? There’s a Shot for That (www.nytimes.com)
This treatment is run illegally, in violation of FDA laws Additionally, it is outlawed in Europe, Canada and Brazil, among other places Lastly, it isn't all that effective, from what I hear, and very painful.  In summary, better options will become available.
Sunil Dhawan, MD, Clinical Assistant Professor of Dermatology
Sunil Dhawan, MD, Clinical Assistant Professor of Dermatology
Stanford University
Analysis of: FDA Issues Warning Letter To Melanocorp, Inc. For Illegal Sale Of Melanotan II -Agency Warns Consumers About Using And Purchasing Unapproved Product (www.medicalnewstoday.com)
 The FDA warning to Melanocorp regarding their product Melanotan was justified. These warnings are far too few and infrequent, and numerous companies make claims without studies or substantiation. The agency is overwhelmed with NDA's, and has difficulty handling the work that currently exists....
Analysis of: Plastic And Reconstructive Surgery Publishes Clinical Trial Results Of Ultrashape(TM) Non Invasive Body Contouring System (www.medicalnewstoday.com)
The idea is very innovative and I am sure will be effective.  The data shows it works and in real clinical experience I have heard that it works.  The results are small, the procedure is extremely slow and cumbersome and the equipment is expensive and large.  Over time, all of these issues...
Michael Bain, MD, Plastic and Reconstructive Physician
Michael A Bain, MD
Analysis of: New Medicare Regulations Adopted To Reduce Certain Hospital Infections And Medical Errors (www.medicalnewstoday.com)
If a patient gets a bedsore, who pays for it? Most importantly, what does this mean to KCI and the other wound companies? Where will it end?
Michael Bain, MD, Plastic and Reconstructive Physician
Michael A Bain, MD
Analysis of: Recurrence of Spider Angiomas After Laser Treatment (dermatology.jwatch.org)
Lasers are better than they were 10 years ago.  Especially for vascular lesions; however, they are not all purpose machines that can do everything, as evidenced by new ones every year.
Analysis of: HMOs to start ad blitz against Medicare cuts (news.yahoo.com)
Now the shoe is on the other foot.  The HMO's, for the most part, treat the physician with disdain.  They neglect to realize that they are simply a conduit for paying the physician with the patient supplying them with money.  They have decided that they have a G-d-given right to meddle...

Previous Page : 1 2 3 4 5 6 7 8 9 10 Next41 to 50 of 92

Analytics


Generated at 2009-01-08T07:00:19.270